3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
8
Hot Flashes
1
Hormone Receptor Positive Breast Carcinoma
1
Endometrial Neoplasms
1
Breast Cancer Female
1
Interventions
Tamoxifen
2
pyrotinib
1
exemestane
1
abemaciclib
1
Surgical Procedures, Operative
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Mammaplasty
1
Letrozole
1
Drug Therapy
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Breast Cancer Female
×
Aromatase Inhibitors
×
Clear all
NCT03917082
2023-06-15
LALEAST
British Columbia Cancer Agency
Phase 2
Active not recruiting
290 enrolled